PUT3 Antibody

Shipped with Ice Packs
In Stock

Description

P3 Monoclonal Antibody (Anti-NeuGcGM3)

P3 mAb is a murine IgM antibody targeting N-glycosylated gangliosides, sulfatides, and tumor-associated antigens in melanoma, breast, and lung cancers .

Key Features:

  • Immunogenicity: Elicits IgG antibody responses in syngeneic BALB/c mice without adjuvants or carrier proteins .

  • Mechanism:

    • Requires CD4+ and CD8+ T cells for immunogenicity .

    • Restores CD8+ T-cell populations in immunosuppressed mice .

    • Enhances rejection of allogeneic tumors (e.g., B16-F10 melanoma) via CD8+ T-cell mediation .

Therapeutic Potential:

ApplicationExperimental OutcomeReference
T-cell recoveryCyclophosphamide-treated mice showed 46% CD4+ and 50% CD8+ T-cell recovery vs. 18–21% in controls .
Tumor rejection19% of P3 mAb-immunized mice developed allogeneic tumors vs. 50% in non-immunized mice .
Adjuvant effectFreund’s adjuvant reduced required P3 mAb doses from 4 to 1 for equivalent IgG responses .

Put3 Transcription Factor in Yeast

Put3 is a proline-dependent transcription factor regulating genes like MCH5 and PUT1/2 in Saccharomyces cerevisiae. While not an antibody, its functional studies provide indirect insights:

Key Findings:

  • Gene Regulation: Binds MCH5 promoter to synchronize proline oxidase biosynthesis .

  • Mutational Activation: Dominant PUT3 mutations enhance target gene expression, improving growth in riboflavin-deficient strains .

Comparative Analysis

ParameterP3 mAbPut3 Protein
TypeIgM monoclonal antibodyTranscription factor
TargetTumor-associated glycolipidsMCH5, PUT1, and PUT2 gene promoters
Role in ImmunityT-cell activation, tumor rejectionMetabolic regulation (proline utilization)
Therapeutic UseImmunotherapy in immunosuppressed modelsN/A (yeast-specific)

Research Gaps and Clarifications

  • Nomenclature Conflict: No direct evidence links "PUT3" to an antibody in the reviewed literature. The term may stem from a typographical error conflating P3 mAb and Put3.

  • Clinical Relevance: P3 mAb’s ability to restore T-cell populations highlights its potential in cancer immunotherapy, but human trials are absent in the provided sources .

Future Directions

  • P3 mAb: Validate efficacy in human trials for lymphopenia or post-chemotherapy immune recovery.

  • Put3: Explore homologs in higher eukaryotes for metabolic or immune-modulatory roles.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PUT3 antibody; YKL015W antibody; Proline utilization trans-activator antibody
Target Names
PUT3
Uniprot No.

Target Background

Function
PUT3 Antibody is a positive activator of the proline utilization pathway. It binds to the promoters of PUT1 and PUT2 genes and recognizes and binds to the DNA sequence 5'-CGG-N(10)-CCG-3'.
Gene References Into Functions
  1. Research has shown that the increased activity of Put3 in one of the suppressor mutants is caused by increased intracellular levels of proline. PMID: 18940788
Database Links

KEGG: sce:YKL015W

STRING: 4932.YKL015W

Subcellular Location
Nucleus.

Q&A

What is PUT3 and why is it important in yeast research?

PUT3 is a transcriptional regulator protein in Saccharomyces cerevisiae (baker's yeast) that controls genes involved in proline utilization. It belongs to the Zn(II)2Cys6 family of transcription factors and acts as an activator of the PUT1 and PUT2 genes, which encode proline oxidase and delta-1-pyrroline-5-carboxylate dehydrogenase, respectively. These enzymes are essential for the catabolism of proline as a nitrogen source. PUT3 is important in research because it serves as a model system for studying transcriptional regulation, nutrient sensing, and adaptive responses in eukaryotes .

What applications are PUT3 antibodies suitable for?

PUT3 antibodies have been validated for several laboratory applications including:

  • Western Blotting (WB): For detecting PUT3 protein in cell lysates and determining its expression levels

  • Enzyme-Linked Immunosorbent Assay (ELISA): For quantifying PUT3 protein in solution

  • Immunofluorescence microscopy: For localizing PUT3 within yeast cells (when performed with appropriate sample preparation)

The commercially available PUT3 antibody from Cusabio is specifically validated for WB and ELISA applications .

How should yeast cells be prepared for immunostaining with PUT3 antibody?

For successful immunostaining of yeast cells with PUT3 antibody, cells should be:

  • Cultured to log phase (5 × 10^6 cells/ml) or diluted 1:100 from stationary culture and grown for 3-5 hours (2-3 doublings)

  • Fixed with 5% formaldehyde (add 0.67 ml of 37% formalin to 5 ml culture) for 1 hour at room temperature

  • Washed twice with 1.2 M sorbitol, 0.1 M potassium phosphate buffer (pH 7.5)

  • Treated with zymolyase (20 μl of 1 mg/ml) and β-mercaptoethanol (1 μl) in the same buffer for 30-40 minutes at 37°C to digest the cell wall

  • Permeabilized with cold methanol (-20°C) for 6 minutes followed by cold acetone (-20°C) for 30 seconds

This preparation ensures proper cell fixation while maintaining antigen accessibility for the antibody.

What controls should be included when using PUT3 antibody?

When performing experiments with PUT3 antibody, the following controls should be included:

Control TypeDescriptionPurpose
Positive controlRecombinant PUT3 protein (provided with some antibodies)Confirms antibody functionality
Negative controlPre-immune serumEstablishes background signal level
PUT3 knockout strainYeast strain with PUT3 gene deletedVerifies antibody specificity
Loading controlAntibody against housekeeping protein (e.g., actin)Normalizes for sample loading variations

Including these controls helps validate results and troubleshoot potential issues with antibody performance .

How can epitope masking issues be addressed when PUT3 antibody fails to detect the protein?

Epitope masking can occur when the PUT3 protein forms complexes with other molecules or undergoes conformational changes that hide antibody binding sites. To address this issue:

  • Try alternative fixation protocols: Replace formaldehyde with methanol fixation or reduce fixation time

  • Optimize antigen retrieval: Use heat-induced epitope retrieval in citrate buffer (pH 6.0) for 10-15 minutes

  • Employ protein denaturation: Add SDS (0.1-0.5%) to disrupt protein-protein interactions

  • Test different detergents: Use NP-40, Triton X-100, or CHAPS at 0.1-0.5% to improve antibody accessibility

  • Modify buffer conditions: Adjust salt concentration (150-500 mM NaCl) to disrupt ionic interactions

When optimizing conditions, maintain stringent controls to ensure specificity is not compromised while improving detection sensitivity .

What are the considerations for detecting PUT3 phosphorylation states?

PUT3 protein can be regulated by phosphorylation, and detecting these modifications requires special considerations:

  • Use phosphorylation-specific antibodies if available, or general phospho-serine/threonine antibodies after PUT3 immunoprecipitation

  • Include phosphatase inhibitors (10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM β-glycerophosphate) in all buffers during sample preparation

  • Consider lambda phosphatase treatment of control samples to confirm phosphorylation-specific signals

  • Use Phos-tag™ acrylamide gels to enhance separation of phosphorylated from non-phosphorylated forms

  • For mass spectrometry analysis of phosphorylation sites, enrich phosphopeptides using TiO2 or immobilized metal affinity chromatography (IMAC)

These approaches can help distinguish between different phosphorylation states of PUT3, which may correlate with its transcriptional activity under various nutritional conditions .

How can researchers optimize co-immunoprecipitation experiments to study PUT3 protein interactions?

To successfully co-immunoprecipitate PUT3 and its interaction partners:

  • Cell lysis buffer selection: Use gentle non-ionic detergents (0.1% NP-40 or 0.5% Triton X-100) in physiological salt conditions (150 mM NaCl) to preserve protein-protein interactions

  • Cross-linking consideration: For transient interactions, use reversible cross-linkers like DSP (dithiobis(succinimidyl propionate)) at 0.5-2 mM for 30 minutes at room temperature

  • Bead selection: Compare Protein A/G beads, magnetic beads, and agarose beads for optimal pull-down efficiency

  • Antibody orientation: Consider using antibody immobilization kits to orient antibodies properly on beads

  • Elution methods: Compare competitive elution with PUT3 peptide versus low pH glycine buffer (50 mM, pH 2.8) followed by immediate neutralization

Validation should include reciprocal co-IPs and controls with non-specific IgG to confirm the specificity of detected interactions .

How should researchers design experiments to study PUT3 localization dynamics during nutrient shifts?

To effectively monitor PUT3 localization changes in response to nutrient availability:

  • Generate a PUT3-GFP fusion protein under its native promoter to monitor localization in living cells

  • Compare with immunofluorescence using PUT3 antibody to validate GFP fusion results

  • Design a time-course experiment with the following components:

    • Start with cells grown in glucose-containing medium without proline

    • Shift cells to proline as the sole nitrogen source and fix/image at intervals (0, 15, 30, 60, 120 minutes)

    • In parallel, prepare samples for Western blotting to correlate localization with expression levels

  • Include co-staining for nuclear markers (e.g., DAPI) and other subcellular compartments

  • Quantify nuclear/cytoplasmic ratios of PUT3 signal at each timepoint using image analysis software

This approach allows correlation of PUT3 localization dynamics with its transcriptional activity during adaptation to different nitrogen sources .

What approaches can resolve contradictory results between PUT3 antibody detection and RNA expression data?

When faced with discrepancies between PUT3 protein levels (detected by antibody) and mRNA expression:

  • Verify antibody specificity:

    • Test the antibody in a PUT3 knockout strain

    • Perform peptide competition assays with the immunizing antigen

    • Use multiple antibodies targeting different epitopes if available

  • Examine post-transcriptional regulation:

    • Measure PUT3 mRNA stability using transcription inhibition (1,10-phenanthroline)

    • Assess translation efficiency with polysome profiling

    • Quantify protein degradation rates using cycloheximide chase experiments

  • Investigate post-translational modifications:

    • Check for proteolytic processing using multiple antibodies targeting different regions

    • Assess ubiquitination status by immunoprecipitation followed by ubiquitin blotting

    • Examine other modifications that might affect antibody binding

  • Consider technical factors:

    • Optimize protein extraction methods for different cellular compartments

    • Test different antibody concentrations and incubation conditions

    • Use recombinant PUT3 protein as a standard curve for absolute quantification

This systematic approach can help identify the source of discrepancies and provide insights into PUT3 regulation .

How can researchers design chromatin immunoprecipitation (ChIP) experiments with PUT3 antibody?

For successful ChIP experiments to identify PUT3 binding sites:

  • Crosslinking protocol:

    • Use 1% formaldehyde for 15 minutes at room temperature

    • Quench with 125 mM glycine for 5 minutes

    • Wash cells three times with cold PBS

  • Chromatin preparation:

    • Lyse cells in 50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate with protease inhibitors

    • Sonicate to generate DNA fragments of 200-500 bp (verify size by agarose gel)

  • Immunoprecipitation conditions:

    • Pre-clear chromatin with Protein A/G beads for 1 hour

    • Incubate with PUT3 antibody at 4 μg per 100 μg chromatin overnight at 4°C

    • Include IgG negative control and positive control for a known transcription factor

  • Washing and elution:

    • Use increasingly stringent washes to reduce background

    • Elute DNA-protein complexes with 1% SDS, 100 mM NaHCO3 at 65°C

  • Reverse crosslinking and DNA purification:

    • Incubate with 200 mM NaCl at 65°C overnight

    • Treat with proteinase K and RNase A

    • Purify DNA using silica columns or phenol-chloroform extraction

The purified DNA can then be analyzed by qPCR for known targets (PUT1/PUT2 promoters) or sequenced for genome-wide binding profile analysis .

How should quantitative Western blot data for PUT3 be normalized and analyzed?

For accurate quantification of PUT3 protein by Western blot:

  • Signal normalization methods:

    • Use total protein normalization with stain-free gels or Ponceau S staining

    • Employ housekeeping proteins (actin, GAPDH) as loading controls

    • Include a dilution series of recombinant PUT3 protein for standard curve generation

  • Quantification approach:

    • Measure band intensity using software (ImageJ, Image Lab, etc.)

    • Subtract local background for each lane

    • Calculate relative expression using the ratio of PUT3 to loading control

  • Statistical analysis:

    • Perform experiments with at least three biological replicates

    • Apply appropriate statistical tests (t-test for pairwise comparisons, ANOVA for multiple conditions)

    • Report results with standard deviation or standard error of the mean

  • Addressing common issues:

    • Non-linear signal: Use exposure times within the linear range of detection

    • High background: Optimize blocking conditions and antibody dilutions

    • Multiple bands: Characterize each band with additional experiments to confirm specificity

This systematic approach ensures reliable and reproducible quantification of PUT3 protein levels across different experimental conditions .

What are the best practices for analyzing PUT3 localization data from immunofluorescence experiments?

For robust analysis of PUT3 localization using immunofluorescence:

  • Image acquisition parameters:

    • Use consistent exposure settings across all samples

    • Capture multiple z-sections to ensure complete cell visualization

    • Include nuclear and cellular markers for reference

  • Quantitative analysis approaches:

    • Measure nuclear/cytoplasmic ratio by defining regions of interest

    • Use automated segmentation algorithms to identify cellular compartments

    • Perform colocalization analysis with organelle markers using Pearson's or Mander's coefficients

  • Statistical considerations:

    • Analyze at least 100 cells per condition for population distribution

    • Use appropriate statistical tests for distribution comparisons (Mann-Whitney U test for non-parametric data)

    • Present data as both population averages and distribution plots

  • Validation strategies:

    • Confirm findings with orthogonal methods (cell fractionation followed by Western blot)

    • Use multiple antibodies or tagged PUT3 constructs to verify localization patterns

    • Perform control experiments with known localization modulators

These practices help ensure that observed PUT3 localization patterns are robustly quantified and biologically meaningful .

How can computational approaches aid in interpreting PUT3 binding specificity data?

Computational methods can enhance the analysis of PUT3 DNA binding specificity:

  • Motif discovery from ChIP-seq data:

    • Use algorithms like MEME, HOMER, or RSAT to identify enriched sequence motifs

    • Compare identified motifs with previously published PUT3 binding sites

    • Analyze flanking sequences for cooperative factor binding sites

  • Integration with gene expression data:

    • Correlate PUT3 binding sites with transcriptional changes in RNA-seq data

    • Identify direct vs. indirect targets based on binding proximity to transcription start sites

    • Perform Gene Ontology enrichment analysis of target genes

  • Network analysis:

    • Construct gene regulatory networks centered on PUT3

    • Identify feedback loops and feed-forward circuits

    • Compare with other transcription factor networks to find common regulatory principles

  • Structural modeling approaches:

    • Use homology modeling to predict PUT3-DNA interactions

    • Perform molecular dynamics simulations to assess binding stability

    • Predict the impact of mutations on binding affinity

These computational approaches can provide mechanistic insights into PUT3 function and generate testable hypotheses for further experimental validation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.